A five-dimension evaluation of Arabic-language health websites providing information about HPV and cervical cancer in the arab world: Readability, engagement, usability, accessibility, and quality

• by Hind Bitar, Sarah Alismail

• October 12, 2026

Daily-life dynamics of general and cognitive fatigue in childhood cancer survivors: An experience sampling and wearable study

• by Deveny Vanrusselt, Charlotte Sleurs, Nicolas Leenaerts, Stefan Kirsch, Nel Van Ermengem, Jurgen Lemiere, Inez Myin-Germeys, Anne Uyttebroeck, Sabine Verschueren

• October 12, 2026

2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC

Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss the results of a new study looking at the impact of food access and poverty on patients with metastatic breast cancer. They also discuss the new Dana-Farber food pantry and patient navigators who help coordinate care.

• October 15, 2026

• 1 min

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

• October 15, 2026

• 1 min